Malaria-infected mice are cured by a single dose of novel artemisinin derivatives

Journal of Medicinal Chemistry

Volumn 50, Issue 10, 2007, Pages 2516-2519

  Posner, Gary H ^a,b   Paik, Ik Hyeon ^a   Chang, Wonsuk ^a   Borstnik, Kristina ^a   Sinishtaj, Sandra ^a   Rosenthal, Andrew S ^a   Shapiro, Theresa A ^b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG SYNTHESIS; MALARIA; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SURVIVAL;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BICYCLO COMPOUNDS, HETEROCYCLIC; MALARIA; MICE; PLASMODIUM BERGHEI; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34249097684     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070149m     Document Type: Article

References (23)

1. Ridley, R. G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002, 415, 686-693.
2. Breman, J.G.; Alilio, M.S.; Mills, A. Conquering the intolerable burden of malaria: What's new, what's needed: A summary. Am. J. Trop. Med. Hyg. 2004, 71, 1-15.
3. Snow, R.W.; Guerra, C. A.; Noor, A. M.; Myint, H. Y.; Hay, S. I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434, 214-217.
4. Drugs for parasitic infections. Med. Lett. 2004, 46, e1-e12.
5. Centers for Disease Control. Guidelines for Treatment of Malaria in the United States. http://www.cdc.gov/malaria/pdf/treatmenttable.pdf (accessed 1/5/07).
6. Shizhen, L. Compendium of Materia Medica (Bencao Gangmu); Foreign Languages Press: Beijing, first published in Chinese in 1593, translation published 2003.
7. Klayman, D. L. Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985, 228, 1049-1055.
8. O'Neill, P. M.; Posner, G. H. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 2004, 47, 2945-2964.
9. Tang, Y.; Dong, Y.; Vennerstrom, J. L. Synthetic peroxides as antimalarials. Med. Res. Rev. 2004, 24, 425-448.
10. Jefford, C. W. Synthetic peroxides as antimalarials. Curr. Opin. Invest. Drugs 2004, 5, 866-872.
11. Woodrow, C. J.; Haynes, R. K.; Krishna, S. Artemisinins. Postgrad. Med. J. 2005, 81, 71-78.
12. Ashley, E. A.; White, N. J. Artemisinin-based combinations. Curr. Opin. Infect. Dis. 2005, 18, 531-536.
13. Adjuik, M.; Babiker, A.; Garner, P.; Olliaro, P.; Taylor, W.; White, N. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004, 363, 9-17.
14. Guidelines for the treatment of malaria; World Health Organization: Switzerland, 2006.
15. Giao, P. T.; Binh, T. Q.; Kager, P. A.; Long, H. P.; Van Thang, N; Van Nam, N.; de Vries, P. J. Artemisinin for treatment of uncomplicated falciparum malaria: Is there a place for monotherapy? Am. J. Trop. Med. Hyg. 2001, 65, 690-695.
16. Posner, G. H.; Paik, I. H.; Sur, S.; McRiner, A. J.; Borstnik, K.; Xie, S.; Shapiro, T. A. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. J. Med. Chem. 2003, 46, 1060-1065.
17. Paik, I. H.; Xie, S.; Shapiro, T. A.; Labonte, T.; Sarjeant, A. A. N.; Baege, A. C.; Posner, G. H. Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity. J. Med. Chem. 2006, 49, 2731-2734.
18. Alagbala, A. A.; McRiner, A. J.; Borstnik, K.; Labonte, T.; Chang, W.; D'Angelo, J. G.; Posner, G. H.; Foster, B. A. Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines. J. Med. Chem. 2006, 49, 7836-7842.
19. Franke-Fayard, B.; Trueman, H.; Ramesar, J.; Mendoza, J.; van der Keur, M.; van der Linden, R.; Sinden, R. E.; Waters, A. P.; Janse, C. J. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 2004, 137, 23-33.
20. Ridley, R. G.; Matile, H.; Jaquet, C.; Dorn, A.; Hofheinz, W.; Leupin, W.; Masciadri, R.; Theil, F. P.; Richter, W. F.; Girometta, M. A.; Guenzi, A.; Urwyler, H.; Gocke, E.; Potthast, J. M.; Csato, M.; Thomas, A.; Peters, W. Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: Comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob. Agents Chemother. 1997, 41, 677-686.
21. Arrow, K. J.; Panosian, C.; Gelband, H. Saving lives, buying time: Economics of malaria drugs in an age of resistance; National Academies Press: Washington, DC, 2004.
22. Ro, D. K.; Paradise, E. M.; Ouellet, M.; Fisher, K. J.; Newman, K. L.; Ndungu, J. M.; Ho, K. A.; Eachus, R. A.; Ham, T. S.; Kirby, J.; Chang, M. C.; Withers, S. T.; Shiba, Y.; Sarpong, R.; Keasling, J. D. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440, 940-943.
23. Liu, C.; Zhao, Y.; Wang, Y. Artemisinin: Current state and perspectives for biotechnological production of an antimalarial drug. Appl. Microbiol. Biotechnol. 2006, 72, 11-20.